Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |